Family doctor advice is the main determinant of pneumococcal vaccine uptake

Journal of Epidemiology and Community Health

Volumn 53, Issue 9, 1999, Pages 589-590

  Kyaw, Moe H ^a   Nguyen Van Tam, Jonathan S ^a   Pearson, James C G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; ASPLENIA; BACTEREMIA; CHRONIC LUNG DISEASE; DIABETES MELLITUS; DRUG USE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HEART DISEASE; HUMAN; IMMUNE DEFICIENCY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; PUBLIC HEALTH; SPLEEN DISEASE;

EID: 0032814329     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.53.9.589     Document Type: Article

References (7)

1. MacFarlane J. The clinical impact of pneumococcal disease. In: Mayon-White RT, ed. The clinical impact of pneumococcal disease and strategies for its prevention. Royal Society of Medicine International Congress and Symposium Series, 210. London: Royal Society of Medicine, 1995:9-17.
2. Laurichesse H, Grimaud O, Waight P, et al. Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Disease and Public Health 1998;1:22-7.
3. Johnson AP, Speller DCE, George RC, et al. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ 1996;312:1454-6.
4. UK Health Departments. Immunisation against infections disease. London: HMSO, 1996.
5. McDonald P, Friedman EHI, Banks A, et al. Pneumococcal vaccine campaign based in general practice. BMJ 1997; 314:1094-8.
6. Anonymous. The place of pneumococcal vaccine. Drug Ther Bull 1998;36(10):73-6.
7. Fedson DS. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. Clin Infect Dis 1998;26:1117-23.